Assessment of LBR-101 In Chronic Migraine
Study Title
- Assessment of LBR-101 In Chronic Migraine
Teva Identifier
- LBR-101-021
ClinicalTrials.gov Identifier
- NCT02021773
Study Status
- Completed
Trial Condition(s)
- Chronic Migraine
Interventions
- Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 65 Years
Trial Duration
- 01/01/2014 - 03/01/2015
Phase
- Phase 2
Study Type
Interventional
